NCT07365826Phase 3Completed

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age

Study sponsor: Vaxcyte, Inc. · PCVX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-10-21Actual
Enrollment · participants1390Actual
Source updated2026-11-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Mar 2027. After: 21 Oct 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 1300 participants (planned). After: 1390 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source